NOVAVAX TO START U.S. TRIAL OF COVID-19 VACCINE LATER THIS MONTH

Highlights

• NVX-CoV2373 was successful in receiving the U.S. Food and Drug Administration's (FDA) fast-track status said Novavax and is also expecting the data from the trial is likely to support US authorization and approval

• This announcement from Novavax comes exactly a day after Pfizer said that it’s COVID-19 vaccine candidate developed along with Germany’s BioNTech was proven 90 percent effe....